Valio continues research into probiotic fruit juices

By Stephen Daniells

- Last updated on GMT

Finnish company Valio is continuing R&D into fruit juice-based
probiotics, with a study in the journal LWT reporting
excellent stability, survivability and tolerability of two strains.

The company has been marketing its Gefilus brand of probiotic juices in Finland since 1997 and says they are now the biggest selling product in Finland's refrigerated juice section.

Adding probiotics to juices is more complex than formulating in dairy products because the bacteria need protection from the acidic conditions in fruit juice.

The new research, led by Tarja Suomalainen from Valio (now with the Raisio Group), looked at using L. rhamnosus​ VTT E-97800 (E800) and L. rhamnosus​ Lc705 in a whey-based fruit juice. The latter was from Valio's commercial Bioprofit product, with the strain P. freudenreichii​ ssp. shermanii​ JS also present.

The strains were added to Valio's commercially available Hedelmätarha product - a whey-based orange drink enriched with calcium. The new formulations were tested in a single blind parallel study with 22 healthy adult volunteers. People with GI tract diseases or recent antibiotic consumption were excluded from the trial.

The trial was designed to give two weeks of baseline control, followed by two weeks of supplementation with either the E800 drink (11 people) or the Lc705 drink (11 people), followed by a final two weeks of follow-up.

"Excellent survival of L. rhamnosus E800 and Lc705 strains during storage in the low pH juice matrix and in the GI-tract was demonstrated in the present study,"​ wrote Suomalainen.

No significant change of immune function of the subjects was observed, although the Lc705 juice drink did decrease the number of IgA cells.

"Although the decrease was statistically significant, it is not certain whether it is biologically relevant,"​ said Suomalainen.

Self-reporting of faecal consistency showed no significant differences, but frequency of defecation increased for the Lc705 group. The E800 group did not report any changes during and after consumption.

"Thus the added bacteria were not disturbing the normal healthy balance in the intestine,"​ concluded Suomalainen.

No one from Valio was available for comment and it is not known if the company will develop these specific whey-based probiotics for commercialisation.

The probiotics market is already one of the fastest growing sectors in fresh dairy markets with a retail growth of about 12 per cent, according to Euromonitor.

The research was published in the journal LWT - Food Science and Technology​ (Vol. 39, pp. 788-795).

Related news

Related products

show more

Embrace the Biotic Edge from Gut to Skin

Embrace the Biotic Edge from Gut to Skin

Content provided by CJ BIO | 08-Nov-2024 | White Paper

Searching for ways to stand out in the market? Dive into our report that analyzes the evolution of the biotics market to identify the key elements driving...

Gut and mental health struggles affect consumers

Gut and mental health struggles affect consumers

Content provided by Verb Biotics | 23-Sep-2024 | White Paper

Verb Biotics, a biotech company focused on improving health through the gut microbiome, recently completed its second annual consumer survey to assess...

Related suppliers

Follow us

Products

View more

Webinars